BAYRY News and Press, Bayer AG ADR From 03/05/24

2024-03-05 10:08:10 ET Bayer AG (BAYZF) Q4 2023 Earnings Conference Call March 05, 2024, 03:30 ET Company Participants Michael Preuss - Head, Communications, Government Relations and Corporate Brand Julio Triana - Head, Commercial Operations Region International ...

2024-03-05 07:41:17 ET Summary Bayer reported full-year results and had to report declines for the top and bottom line. Management cut the dividend to 11 cents in order to get the huge debt levels under control. The stock might still be undervalued but with all the risks surro...

2024-03-05 07:20:32 ET More on Bayer Bayer: Long-Term Upside After The Dividend Cut Bayer Isn't Dead Seeking Alpha's Quant Rating on Bayer Read the full article on Seeking Alpha For further details see: Bayer will not split into separate units for...

Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...

First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...

2024-02-25 12:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Phase 3 data for As...

2024-02-21 07:13:01 ET Regeneron ( NASDAQ: REGN ) and Vertex Pharmaceuticals ( NASDAQ: VRTX ) have crossed $100B in market capitalization for the first time, joining two other giants in the biotech industry, Amgen ( AMGN ) and AbbVie ( ABBV ).... Read the full ...

2024-02-20 14:38:36 ET Summary Bayer recently cut its dividend by more than 90%, resulting in a dividend yield of less than 1%. The company's valuation actually rose after the dividend cut, indicating investor approval. Bayer's risks include ongoing litigation related to glyph...

2024-02-19 18:08:23 ET More on Bayer, Bayer AG, etc. Bayer Isn't Dead U.S. appeals court refuses to shield Bayer from Roundup lawsuit Bayer slumps after $2.25B jury award on Roundup damages claim Seeking Alpha’s Quant Rating on Bayer Historical...

2024-02-18 11:30:00 ET Summary Broyhill Asset Management is a boutique investment firm guided by a disciplined value orientation. We operate outside of the fray and invest with a rational, objective, long-term perspective. The largest contributors to the portfolio's performance fo...